EDIT | Editas Medicine Inc. Analyst Estimates | MarketWatch Nov 06, 2019 · Editas Medicine Inc. analyst estimates by MarketWatch. View EDIT revenue estimates and earnings estimates, as well as analyst recommendations. My Recent Quotes | Stock Prices | Yahoo Finance At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Time and Sales - Intraday Stock Last Price History for ...
Editas Medicine Inc Stock Price Chart. Analyze EDIT ... Apr 15, 2019 · Editas Medicine Inc live price charts and stock performance over time. Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons. EDI Stock Price, Forecast & News (Stone Harbor Emerging ... Analyzing Stone Harbor Emerging Mkt Total Incom FD (NYSE:EDI) stock? View EDI's stock price, price target, dividend, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.
Oct 28, 2019 · The jobless-claims report is ominous, but there’s a better early warning indicator for stock investors. 9:50a. U.S. trade deficit narrows 12.2% in February to $39.9 billion. 9:50a Editas Medicine, Inc. Common Stock (EDIT) Historical Data ... Find the latest historical data for Editas Medicine, Inc. Common Stock (EDIT) at Nasdaq.com. EDIT Historical Stock Prices
ATK (ATK) has the following price history information. Looking back at ATK historical stock prices for the last five trading days, on February 03, 2015, ATK opened at $131.91, traded as high as $136.43 and as low as $131.80, and closed at $136.35. Trading volume was a total of 635.80K shares. On February 04, 2015, ATK opened at $137.17, traded as high as $140.39 and as low as $136.07, and Editas Medicine, Inc. (EDIT) Stock Message Board ... Add EDIT Price Alert Hide Sticky Hide Intro Moderator: Search This Board: 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003+ E DIGITAL CORP - EDIG - Stock Price & News | The Motley Fool
Nov 05, 2019 · 2 Wall Street analysts have issued ratings and price targets for Gevo in the last 12 months. Their average twelve-month price target is $6.50, suggesting that the stock has a possible upside of 685.50%. The high price target for GEVO is $10.00 and the low price target for GEVO is $3.00.